
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
ERp72 CRISPR/Cas9 KO Plasmid (m) | sc-419416 | 20 µg | $397.00 |
Mouse Pdia4 encodes ERp72, a protein disulfide isomerase family member that resides in the endoplasmic reticulum and catalyzes thiol–disulfide exchange during oxidative protein folding. ERp72 supports ER quality control by promoting correct disulfide bond formation and cooperating with chaperone networks that govern folding, assembly, and retention of secretory and membrane proteins. Through its roles in proteostasis, Pdia4 is functionally linked to ER stress signaling and unfolded protein response pathways that shape redox balance and cell fate decisions under conditions of high secretory load. Altered PDI activity and ER stress adaptation are frequently studied in contexts such as inflammation, metabolic dysfunction, and cancer biology, where secretory pathway homeostasis and oxidative folding capacity can influence disease-relevant phenotypes.
ERp72 CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Pdia4 gene in mouse cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the Pdia4 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the Pdia4 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish ERp72 protein expression.
This CRISPR knockout system enables efficient generation of Pdia4-deficient cell models for investigation of ERp72 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.